In support of this concept, induction of Th17 cells to IFN-γ-secreting Th1 cells and differentiation into a durable stem memory phenotype enhances long-term anti-tumor responses (37, 40), and this feature has been applied in adoptive T cell transfer therapy in a murine preclinical model (41). This evidence concerns the gene IFNG and neoplasm.